gebhart/patrepeval huggingface dataset:
Clinical standards for patient blood management and perioperative hemostasis and coagulation management. Position Paper of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) (2019)

Patient blood management is currently defined as the application of evidence based medical and surgical concepts designed to maintain hemoglobin (Hb), optimize hemostasis and minimize blood loss to improve patient outcome. Blood management focus on the perioperative management of patients undergoing surgery or other invasive procedures in which significant blood loss occurs or is expected. Preventive strategies are emphasized to identify and manage anemia, reduce iatrogenic blood losses, optimize hemostasis (e.g. pharmacologic therapy, and point of care testing); establish decision thresholds for the appropriate administration of blood therapy. This goal was motivated historically by known blood risks including transmissible infectious disease, transfusion reactions, and potential effects of immunomodulation. Patient blood management has been recognized by the World Health Organization (WHO) as the new standard of care and has urged all 193-member countries of WHO to implement this concept. There is a pressing need for this new "standard of care" so as to reduce blood transfusion and promote the availability of transfusion alternatives. Patient blood management therefore encompasses an evidence-based medical and surgical approach that is multidisciplinary (transfusion medicine specialists, surgeons, anesthesiologists, and critical care specialists) and multiprofessional (physicians, nurses, pump technologists and pharmacists). The Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) organized a consensus project involving a Task Force of expert anesthesiologists that reviewing literature provide appropriate levels of care and good clinical practices. Hence, this article focuses on achieving goals of PBM in the perioperative period.
SPAC: Serial Protocol for the Atlas Calorimeter 093 (1998)

The aim of this protocol is to provide the loading and reading of all registers and memories sitted on the calorimeter of the ATLAS detector.It has been studied to be fast (10Mbit/s), reliable (the error detection rate is high) and cheap.The slave interface fits in an unique circuit and offers several facilities ( SPAC -> VME transcoder to drive a VME bus thus allowing crate interconnections, JTAG outputs for on board FPGA programming, ...).The SPAC bus can be PECL/BTL and uni/bidirectionnal.The user's software is written in C, and graphic interfaces are running on UNIX and MacIntosh.The SPAC bus induces very low noise and small power consumption.The protocol is simple and powerful, and allows a immediate understanding of data transfers with an oscilloscope.As the possibilities of the SPAC bus seem wide, it could also be used for many other applications.
Effect of feed supplementation with kynurenic acid on the morphology of the liver, kidney and gills in rainbow trout (Oncorhynchus mykissWalbaum, 1792), healthy and experimentally infected withYersinia ruckeri (2016)

Kynurenic acid (KYNA) is an endogenous substance produced on the kynurenine pathway which is primarily known for its neuroactive properties. Recently, it has been proven that KYNA is a selective ligand for G protein-coupled receptor (GPR 35), presented on immunocompetent cells such as T lymphocytes. This opens up new possibilities of its application as an immunostimulating substance in aquaculture. Thus far, no histopathological investigations in fish have been completed to evaluate influence of KYNA supplementation in feed. This study has been undertaken to determine the effect of feed supplementation with KYNA (2.5, 25, 250 mg kg<sup>-1</sup> of feed) for 28 days on the liver, gills and kidney in healthy fish and experimentally infected with Yersinia ruckeri. In a control group were observed a fatty liver, which is natural for this fish species in the autumn and winter season. As the dose of the supplement was increased, the fat liver changed, it decreased or completely disappeared. Additionally, inflammatory changes occurred in all the analysed organs, and their intensification was dose dependent. In the fish experimentally infected, KYNA caused aggravation of the signs in the liver, kidneys and gills, and the effect was dose dependent. The results implicate that KYNA may be a stressor for fish.
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients (2010)

With increasing numbers of immune-compromised patients with malignancy, hematologic disease, and HIV, as well as those receiving immunosupressive drug regimens for the management of organ transplantation or autoimmune inflammatory conditions, the incidence of fungal infections has dramatically increased over recent years. Definitive diagnosis of pulmonary fungal infections has also been substantially assisted by the development of newer diagnostic methods and techniques, including the use of antigen detection, polymerase chain reaction, serologies, computed tomography and positron emission tomography scans, bronchoscopy, mediastinoscopy, and video-assisted thorascopic biopsy. At the same time, the introduction of new treatment modalities has significantly broadened options available to physicians who treat these conditions. While traditionally antifungal therapy was limited to the use of amphotericin B, flucytosine, and a handful of clinically available azole agents, current pharmacologic treatment options include potent new azole compounds with extended antifungal activity, lipid forms of amphotericin B, and newer antifungal drugs, including the echinocandins. In view of the changing treatment of pulmonary fungal infections, the American Thoracic Society convened a working group of experts in fungal infections to develop a concise clinical statement of current therapeutic options for those fungal infections of particular relevance to pulmonary and critical care practice. This document focuses on three primary areas of concern: the endemic mycoses, including histoplasmosis, sporotrichosis, blastomycosis, and coccidioidomycosis; fungal infections of special concern for immune-compromised and critically ill patients, including cryptococcosis, aspergillosis, candidiasis, and Pneumocystis pneumonia; and rare and emerging fungal infections.
A 12b 1GS/s SiGe BiCMOS two-way time-interleaved pipeline ADC (2011)

Pipelined ADCs designed in analog BiCMOS technologies can offer good linearity and high SNR performance for input signals with reasonable voltage swings. Such ADCs, however, face two critical design challenges: the process limits the sampling rate, and the pipeline architecture limits power efficiency. This paper introduces a two-way time-interleaved (TI) switched-current 1Gs/s 12b pipelined ADC in SiGe BiCMOS that addresses these issues.
The Nature of Collusion Facilitating and Collusion Breaking Power of Simultaneous Ascending Price and Simultaneous Descending Price Auctions (2007)

This paper demonstrates that a robust, tacit collusion evolves quickly in a collusion incubator environment, but is destroyed by the simultaneous, descending price auction. Theories of collusion-producing behavior, along with the detail of the states on which strategies are conditioned, lead to a deeper understanding of how tacit collusion evolves and its necessary conditions. These theories explain how the descending price auction destroys the collusion. The experiments proceed by conducting simultaneous ascending price auctions in the collusion incubator. Then, once the tacit collusion developed, changing to the descending auction. The change moved prices from collusive levels to near competitive levels.
Clinical Images - A Quarterly Column: Rare Neonatal Look at Chiari II Thoracic Myelomeningocele. (2015)

Chiari II malformation is a complex constellation of findings resulting from an open neural tube defect that may manifest with malformations of the skull, dura, hindbrain, cerebellum, midbrain, posterior cerebrum, and spinal cord. An uncommonly imaged yet defining characteristic of the Chiari II malformation is a myelomeningocele.
Shark (2013)

Shark is a new data analysis system that marries query processing with complex analytics on large clusters. It leverages a novel distributed memory abstraction to provide a unified engine that can run SQL queries and sophisticated analytics functions (e.g. iterative machine learning) at scale, and efficiently recovers from failures mid-query. This allows Shark to run SQL queries up to 100X faster than Apache Hive, and machine learning programs more than 100X faster than Hadoop. Unlike previous systems, Shark shows that it is possible to achieve these speedups while retaining a MapReduce-like execution engine, and the fine-grained fault tolerance properties that such engine provides. It extends such an engine in several ways, including column-oriented in-memory storage and dynamic mid-query replanning, to effectively execute SQL. The result is a system that matches the speedups reported for MPP analytic databases over MapReduce, while offering fault tolerance properties and complex analytics capabilities that they lack.
Biological dose optimization with multiple ion fields (2008)

We describe a method to irradiate arbitrarily shaped target volumes with simultaneously optimized multiple fields of fast carbon ions, explicitly taking into account sparing of organs at risk. The method was developed with realistic technical boundary conditions in mind, so that irradiations can be executed with devices like the GSI raster scanner or its successors at the upcoming dedicated ion-beam radiotherapy facilities. By virtue of the local effect model (LEM) biological effects are fully taken into account. Several minimization algorithms were investigated, and plain gradient search was found to be more effective than methods based on conjugate gradients or Newton's root finding algorithm. Two sets of cell survival experiments for the experimental verification of patient-like treatment plans were performed. Chinese hamster cells were used for quasi two-dimensional biological dosimetry. The plans combine a very good target conformation with an excellent sparing of organs-at-risk which was verified by the measurements. The results are compared to predictions of the local effect model in its original formulation and a modified version taking additional effects of clustered DNA damage into account. The new method is implemented in GSI's TRiP98 treatment planning system. It has already been applied clinically for planning and irradiating selected patients within the GSI pilot project.
Corneal biomechanics measured with the ocular response analyser in patients with unilateral open-angle glaucoma (2011)

Corneal hysteresis but not corneal resistance factor is dependent on IOP. In patients with unilateral POAG, IOP is higher in the affected eye. When CH is corrected for IOP, corneal biomechanical properties do not differ in both eyes of patients with unilateral POAG.
Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging (2016)

Retinoblastoma (RB) is an intraocular childhood tumor which, if left untreated, leads to blindness and mortality. Nucleolin (NCL) protein which is differentially expressed on the tumor cell surface, binds ligands and regulates carcinogenesis and angiogenesis. We found that NCL is over expressed in RB tumor tissues and cell lines compared to normal retina. We studied the effect of nucleolin-aptamer (NCL-APT) to reduce proliferation in RB tumor cells. Aptamer treatment on the RB cell lines (Y79 and WERI-Rb1) led to significant inhibition of cell proliferation. Locked nucleic acid (LNA) modified NCL-APT administered subcutaneously (s.c.) near tumor or intraperitoneally (i.p.) in Y79 xenografted nude mice resulted in 26 and 65% of tumor growth inhibition, respectively. Downregulation of inhibitor of apoptosis proteins, tumor miRNA-18a, altered serum cytokines, and serum miRNA-18a levels were observed upon NCL-APT treatment. Desorption electrospray ionization mass spectrometry (DESI MS)-based imaging of cell lines and tumor tissues revealed changes in phosphatidylcholines levels upon treatment. Thus, our study provides proof of concept illustrating NCL-APT-based targeted therapeutic strategy and use of DESI MS-based lipid imaging in monitoring therapeutic responses in RB.
N-Substituted Acyclopurinenucleosides with Antiviral Activity (1985)

Abstract N-Substituted Glyceropurines have been prepared. The N-dimethylaminomethyleneated and N-acetylated glyceroguanine derivatives have significant activity against Herpesviruses.
ChemInform Abstract: Soft Lithography (1998)

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Automated optoacoustic spectrometer for the near-infrared range based on a color-center laser and its applications in the spectroscopy of molecular gas overtones (1985)

A description is given of the construction and characteristics of an optoacoustic gas absorption spectrometer based on an LiF :F2− laser operating in the rarely employed spectral range 1.10–1.22 μ. Optimization of the parameters of the color-center laser and of the optoacoustic detector made it possible to achieve a high sensitivity (10−7 cm−1) in a wide dynamic range with a spectral resolution of 0.1 cm−1 . The spectrometer was found to be suitable for the study of overtone vibrational states of molecular gases.
Data from Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by <i>Nanoparticle Albumin-Bound</i>–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma (2023)

&lt;div&gt;Abstract&lt;p&gt;The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of drug resistance, underscoring the role of mTOR inhibitors, such as rapamycin, with potential anti-MM activity. However, recent data show a positive feedback loop from mTOR/S6K1 to Akt, whereby Akt activation confers resistance to mTOR inhibitors. We confirmed that suppression of mTOR signaling in MM cells by rapamycin was associated with upregulation of Akt phosphorylation. We hypothesized that inhibiting this positive feedback by a potent Akt inhibitor perifosine would augment rapamycin-induced cytotoxicity in MM cells. Perifosine inhibited rapamycin-induced phosphorylated Akt, resulting in enhanced cytotoxicity in MM.1S cells even in the presence of interleukin-6, insulin-like growth factor-I, or bone marrow stromal cells. Moreover, rapamycin-induced autophagy in MM.1S MM cells, as evidenced by electron microscopy and immunocytochemistry, was augmented by perifosine. Combination therapy increased apoptosis detected by Annexin V/propidium iodide analysis and caspase/poly(ADP-ribose) polymerase cleavage. Importantly, &lt;i&gt;in vivo&lt;/i&gt; antitumor activity and prolongation of survival in a MM mouse xenograft model after treatment was enhanced with combination of &lt;i&gt;nanoparticle albumin-bound&lt;/i&gt;–rapamycin and perifosine. Utilizing the &lt;i&gt;in silico&lt;/i&gt; predictive analysis, we confirmed our experimental findings of this drug combination on PI3K, Akt, mTOR kinases, and the caspases. Our data suggest that mutual suppression of the PI3K/Akt/mTOR pathway by rapamycin and perifosine combination induces synergistic MM cell cytotoxicity, providing the rationale for clinical trials in patients with relapsed/refractory MM. Mol Cancer Ther; 9(4); 963–75. ©2010 AACR.&lt;/p&gt;&lt;/div&gt;
Structured Prediction as Translation between Augmented Natural Languages (2021)

We propose a new framework, Translation between Augmented Natural Languages (TANL), to solve many structured prediction language tasks including joint entity and relation extraction, nested named entity recognition, relation classification, semantic role labeling, event extraction, coreference resolution, and dialogue state tracking. Instead of tackling the problem by training task-specific discriminative classifiers, we frame it as a translation task between augmented natural languages, from which the task-relevant information can be easily extracted. Our approach can match or outperform task-specific models on all tasks, and in particular, achieves new state-of-the-art results on joint entity and relation extraction (CoNLL04, ADE, NYT, and ACE2005 datasets), relation classification (FewRel and TACRED), and semantic role labeling (CoNLL-2005 and CoNLL-2012). We accomplish this while using the same architecture and hyperparameters for all tasks and even when training a single model to solve all tasks at the same time (multi-task learning). Finally, we show that our framework can also significantly improve the performance in a low-resource regime, thanks to better use of label semantics.
Seleno-Auranofin (Et3PAuSe-tagl): Synthesis, Spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) Characterization, Biological Activity, and Rapid Serum Albumin-Induced Triethylphosphine Oxide Generation (2010)

Seleno-auranofin (SeAF), an analogue of auranofin (AF), the orally active antiarthritic gold drug in clinical use, was synthesized and has been characterized by an array of physical techniques and biological assays. The Mössbauer and extended X-ray absorption fine structure (EXAFS) parameters of the solid compound demonstrate a linear P-Au-Se coordination environment at a gold(I) center, analogous to the structure of auranofin. The (31)P, (13)C, and (1)H NMR spectra of SeAF in chloroform solution closely resemble those of auranofin. The (77)Se spectrum consists of a singlet at 481 ppm, consistent with a metal-bound selenolate ligand. The absence of (2)J(PSe) coupling in the (31)P and (77)Se spectra may arise from dynamic processes occurring in solution or because the (2)J(PSe) coupling constants are smaller than the observed bandwidths. Electrospray ionization mass spectrometry (ESI-MS) spectra of SeAF in 50:50 methanol-water exhibited strong signals for [(Et(3)P)(2)Au](+), [(Et(3)PAu)(2)-mu-Se-tagl](+), and [Au(Se-tagl)(2)](-), which arise from ligand scrambling reactions. Three assays of the anti-inflammatory activity of SeAF allowed comparison to AF. SeAF exhibited comparable activity in the topically administered murine arachadonic acid-induced and phorbol ester-induced anti-inflammatory assays but was inactive in the orally administered carrageenan-induced assay in rats. However, in vivo serum gold levels were comparable in the rat, suggesting that differences between the in vivo metabolism of the two compounds, leading to differences in transport to the inflamed site, may account for the differential activity in the carrageenan-induced assay. Reactions of serum albumin, the principal transport protein of gold in the serum, demonstrated formation of AlbSAuPEt(3) at cysteine 34 and provided evidence for facile reduction of disulfide bonds at cysteine 34 and very rapid formation of Et(3)P=O, a known metabolite of auranofin.
Safety and Efficacy of Long-Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension (2016)

Introduction: Ozanimod (RPC1063) is an oral, selective sphingosine 1-phosphate (S1P) 1 and 5 receptor modulator in clinical development for the treatment of Inflammatory Bowel Disease (ulcerative colitis [UC] and Crohn's disease) and relapsing multiple sclerosis. The objective of the open-label extension (OLE) of the TOUCHSTONE trial is to evaluate the long-term efficacy and safety of daily 1 mg ozanimod in patients with moderate to severe UC who had initially participated in the TOUCHSTONE trial. Methods: A total of 197 patients were randomized (1:1:1) and treated with daily ozanimod at 0.5 mg, 1mg (n=67), or placebo in the TOUCHSTONE trial. Of the initial 197 patients randomized, 170 (86%) entered the OLE and received daily 1 mg ozanimod, 131 (77%) completed the Week 44 assessments, and 109 (64%) remained in the OLE as of the data cut-off (March 2016). At the data cut-off, all remaining patients had received treatment in the OLE for ≥ 1 year. Results: At entry into the OLE, the partial Mayo Score (pMS) for patients on placebo, ozanimod 0.5 mg, and 1.0 mg was 4.6, 4.5, and 3.3 respectively. The pMS had improved in all groups (1.7, 1.7, and 1.9) at Week 44. The greatest improvement was reported in patients who received placebo or ozanimod 0.5 mg in the TOUCHSTONE trial with a change in pMS at Week 44 of -2.6, -2.7 and -1.3 in the placebo, 0.5 mg and 1 mg groups. Improvement occurred rapidly, in the first 4 to 8 weeks of the OLE with a change in pMS at Week 4 of -1.8, -1.5 and -0.8 and a change in pMS at Week 8 of -2.4, -1.9 and -1.1 in the placebo, 0.5 mg and 1 mg groups. At the Week 44 visit in the OLE, 119/131 (90.9%) had little or no active disease based on the physician global assessment (PGA 0 or 1), 129/131 (98.4%) had little or no blood in their stools (rectal bleeding subscore [RBS] 0 or 1), 111/131 (84.7%) had no blood in the stools (RBS 0). The most common adverse events (AEs) (>2.0%) during OLE were UC flare, anemia, upper respiratory tract infection, nasal pharyngitis, back pain, arthralgia, headache, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) elevation. The only serious AEs in ≥2 patients were anemia, and ulcerative colitis flare. ALT and AST > 3x upper limit of normal occurred in 4 (2.4%) of the 170 patients in the OLE. All elevations were asymptomatic, < 5xULN, transient, and resolving while receiving continued treatment. Conclusion: Long-term treatment with ozanimod continues to be safe and well tolerated with good compliance and evidence of durable efficacy.
ChemInform Abstract: Rocking Chair Lithium Battery Based on Nanocrystalline TiO2 (Anatase). (1996)

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Supplementary Database 1 from Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation (2023)

Supplementary Database 1 from Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation
The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells. (1998)

The mammalian genome encodes at least nine different members of the ClC family of chloride channels. So far only two of them could be localized on a cellular level in the kidney. We now report on the precise intrarenal localization of the mRNAs coding for the chloride channels ClC-2, ClC-3 and ClC-5. Expression of ClC-2 mRNA, encoding a swelling-activated chloride channel, could be demonstrated in the S3 segment of the proximal tubule. The chloride channel ClC-3 mRNA and ClC-5 mRNA, coding for a chloride channel mutated in kidney stone disease, were both expressed in intercalated cells of the connecting tubule and collecting duct. Whereas ClC-3 mRNA expression was most prominent in the cortex of rat kidneys, ClC-5 mRNA was expressed from the cortex through the upper portion of the inner medulla. A detailed analysis revealed that ClC-3 was expressed by type B intercalated cells, whereas ClC-5 was expressed by type A intercalated cells. These findings have important implications for the pathogenesis of hereditary kidney stone disease caused by mutations in the CLCN5 gene.
Células solares fotoelectroquímicas basadas en esponjas fotónicas (2007)

Referencia OEPM: P200501420.-- Fecha de solicitud: 03/06/2005.-- Titulares: Universidad Politécnica de Valencia (UPV), Consejo Superior de Investigaciones Científicas (CSIC).